Current insights into CD4+ T cell subset regulation during fungal infections reveal three translationally promising strategies: (1) enhancing protective immunity—IFN-γ therapy to augment Th1-mediated responses has significantly improved clinical outcomes in fungal sepsis. This evidence concerns the gene CD4 and fungal infectious disease.